Livforsakringsbolaget Skandia, Omsesidigt Thermo Fisher Scientific Inc. Transaction History

Livforsakringsbolaget Skandia, Omsesidigt

$1.72 Billion
Q3 2024

A detailed history of Livforsakringsbolaget Skandia, Omsesidigt transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Livforsakringsbolaget Skandia, Omsesidigt holds 5,080 shares of TMO stock, worth $2.62 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

5,080

Previous 2,348 116.35%

Holding current value

$2.62 Million

Previous $1.3 Million 142.06%

% of portfolio

0.18%

Previous 0.11%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	BUY	$531.86 - $624.21 $1.45 Million - $1.71 Million	2,732 Added 116.35%	5,080 $3.14 Million
Q2 2024 Jul 15, 2024	SELL	$541.52 - $599.02 $108,304 - $119,804	-200 Reduced 7.85%	2,348 $1.3 Million
Q4 2023 Jan 31, 2024	BUY	$431.41 - $532.94 $91,027 - $112,450	211 Added 9.03%	2,548 $1.35 Million
Q3 2023 Oct 20, 2023	SELL	$498.29 - $574.41 $49,829 - $57,441	-100 Reduced 4.1%	2,337 $1.18 Million
Q2 2023 Jul 06, 2023	SELL	$508.46 - $591.13 $101,692 - $118,226	-200 Reduced 7.58%	2,437 $1.27 Million
Q3 2022 Nov 14, 2022	SELL	$507.19 - $604.49 $1.31 Million - $1.56 Million	-2,580 Reduced 49.45%	2,637 $1.34 Million
Q2 2022 Aug 16, 2022	SELL	$500.9 - $612.21 $651,170 - $795,873	-1,300 Reduced 19.95%	5,217 $2.83 Million
Q1 2022 Jun 21, 2022	SELL	$524.0 - $644.92 $974,640 - $1.2 Million	-1,860 Reduced 22.2%	6,517 $3.85 Million
Q4 2021 Feb 14, 2022	SELL	$569.0 - $667.24 $967,300 - $1.13 Million	-1,700 Reduced 16.87%	8,377 $5.59 Million
Q3 2021 Oct 28, 2021	SELL	$509.53 - $609.78 $560,483 - $670,758	-1,100 Reduced 9.84%	10,077 $5.75 Million
Q2 2021 Jul 13, 2021	SELL	$441.0 - $508.24 $110,250 - $127,060	-250 Reduced 2.19%	11,177 $5.64 Million
Q1 2021 May 07, 2021	BUY	$439.85 - $518.83 $395,865 - $466,947	900 Added 8.55%	11,427 $5.22 Million
Q4 2020 Mar 02, 2021	BUY	$435.06 - $527.66 $739,602 - $897,022	1,700 Added 19.26%	10,527 $4.9 Million
Q3 2020 Nov 09, 2020	SELL	$359.77 - $441.52 $107,931 - $132,456	-300 Reduced 3.29%	8,827 $3.9 Million
Q1 2020 Apr 22, 2020	BUY	$255.3 - $340.05 $306,360 - $408,060	1,200 Added 15.14%	9,127 $2.59 Million
Q4 2019 Jan 28, 2020	SELL	$271.93 - $328.04 $407,895 - $492,060	-1,500 Reduced 15.91%	7,927 $2.58 Million
Q3 2019 Oct 29, 2019	BUY	$268.46 - $305.43 $2.53 Million - $2.88 Million	9,427 New	9,427 $2.75 Million
Q2 2019 Jul 19, 2019	SELL	$257.51 - $295.55 $1.03 Million - $1.18 Million	-3,997 Closed	0 $0
Q1 2019 May 09, 2019	BUY	$212.17 - $273.72 $84,868 - $109,488	400 Added 11.12%	3,997 $1.09 Million
Q3 2018 Oct 26, 2018	SELL	$205.57 - $244.32 $719,495 - $855,120	-3,500 Reduced 49.32%	3,597 $878,000
Q2 2018 Jul 10, 2018	BUY	$203.14 - $219.53 $203,140 - $219,530	1,000 Added 16.4%	7,097 $1.47 Million
Q4 2017 Jan 18, 2018	SELL	$182.03 - $200.37 $254,842 - $280,518	-1,400 Reduced 18.67%	6,097 $1.16 Million
Q3 2017 Oct 12, 2017	BUY	$171.74 - $194.04 $1.29 Million - $1.45 Million	7,497	7,497 $1.42 Million

Others Institutions Holding TMO

# of Institutions

2,829

Shares Held

334M

Call Options Held

2.37M

Put Options Held

2.75M

View Full List

About THERMO FISHER SCIENTIFIC INC.

Ticker TMO
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 391,788,992
Market Cap $202B
Description
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...

More about TMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Livforsakringsbolaget Skandia, Omsesidigt, based on Form 13F filings with the SEC.

News

Stay updated on Livforsakringsbolaget Skandia, Omsesidigt with notifications on news.

Account

Livforsakringsbolaget Skandia, Omsesidigt Thermo Fisher Scientific Inc. Transaction History